Mangalam Drugs & Organics Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 1,077 million compared to INR 1,047.78 million a year ago. Revenue was INR 1,095.02 million compared to INR 1,053.01 million a year ago. Net income was INR 30.04 million compared to INR 44.16 million a year ago. Basic earnings per share from continuing operations was INR 1.92 compared to INR 2.79 a year ago. Diluted earnings per share from continuing operations was INR 1.92 compared to INR 2.79 a year ago.